[1] D M Coward, et al. The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954. Psychopharmacology (Berl). 1977 Apr 29;52(2):165-71. DOI:
10.1007/BF00439104[2] C Mitra, et al. Monoamine oxidase inhibition by the tremorogenic drug--LON 954. J Pharm Pharmacol. 1984 Jun;36(6):408-10. DOI:
10.1111/j.2042-7158.1984.tb04411.x
